• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

儿童癌症患者报告结局指标综述

A Review of Patient-Reported Outcome Measures in Childhood Cancer.

作者信息

Horan Madeline R, Sim Jin-Ah, Krull Kevin R, Baker Justin N, Huang I-Chan

机构信息

Department of Epidemiology and Cancer Control, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.

School of AI Convergence, Hallym University, Chuncheon 200160, Korea.

出版信息

Children (Basel). 2022 Sep 30;9(10):1497. doi: 10.3390/children9101497.

DOI:10.3390/children9101497
PMID:36291433
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9601091/
Abstract

Patient-reported outcomes (PROs) are used in clinical work and research to capture the subjective experiences of childhood cancer patients and survivors. PROs encompass content domains relevant and important to this population, including health-related quality-of-life (HRQOL), symptoms, and functional status. To inform future efforts in the application of PRO measures, this review describes the existing generic and cancer-specific PRO measures for pediatric cancer populations and summarizes their characteristics, available language translations, content coverage, and measurement properties into tables for clinicians and researchers to reference before choosing a PRO measure that suits their purpose. We have identified often unreported measurement properties that could provide evidence about the clinical utility of the PRO measures. Routine PRO assessment in pediatric cancer care offers opportunities to facilitate clinical decision-making and improve quality of care for these patients. However, we suggest that before implementing PRO measures into research or clinical care, the psychometric properties and content coverage of the PRO measures must be considered to ensure that PRO measures are appropriately assessing the intended construct in childhood cancer patients.

摘要

患者报告结局(PROs)在临床工作和研究中用于获取儿童癌症患者及其幸存者的主观体验。PROs涵盖了与该人群相关且重要的内容领域,包括健康相关生活质量(HRQOL)、症状和功能状态。为了为未来PRO测量的应用提供参考,本综述描述了现有的针对儿科癌症人群的通用和癌症特异性PRO测量方法,并将其特征、可用语言翻译、内容覆盖范围和测量属性汇总成表格,供临床医生和研究人员在选择适合其目的的PRO测量方法之前参考。我们确定了一些经常未报告的测量属性,这些属性可以为PRO测量方法的临床实用性提供证据。儿科癌症护理中的常规PRO评估为促进临床决策和提高这些患者的护理质量提供了机会。然而,我们建议在将PRO测量方法应用于研究或临床护理之前,必须考虑PRO测量方法的心理测量属性和内容覆盖范围,以确保PRO测量方法能够适当地评估儿童癌症患者的预期结构。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/482c/9601091/bdfa57d51921/children-09-01497-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/482c/9601091/bdfa57d51921/children-09-01497-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/482c/9601091/bdfa57d51921/children-09-01497-g001.jpg

相似文献

1
A Review of Patient-Reported Outcome Measures in Childhood Cancer.儿童癌症患者报告结局指标综述
Children (Basel). 2022 Sep 30;9(10):1497. doi: 10.3390/children9101497.
2
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
3
Ten Considerations for Integrating Patient-Reported Outcomes into Clinical Care for Childhood Cancer Survivors.将患者报告结局纳入儿童癌症幸存者临床护理的十点考量
Cancers (Basel). 2023 Feb 6;15(4):1024. doi: 10.3390/cancers15041024.
4
Patient-Reported Outcome Measures in Safety Event Reporting: PROSPER Consortium guidance.患者报告的安全事件报告中的结局指标:PROSPER 联盟指南。
Drug Saf. 2013 Dec;36(12):1129-49. doi: 10.1007/s40264-013-0113-z.
5
Recommendations on evidence needed to support measurement equivalence between electronic and paper-based patient-reported outcome (PRO) measures: ISPOR ePRO Good Research Practices Task Force report.关于支持电子和纸质患者报告结局(PRO)测量等效性所需证据的建议:国际药物经济学与结果研究协会(ISPOR)电子PRO良好研究实践工作组报告
Value Health. 2009 Jun;12(4):419-29. doi: 10.1111/j.1524-4733.2008.00470.x. Epub 2008 Nov 11.
6
Assessing health-related quality of life (HRQoL) in survivors of out-of-hospital cardiac arrest: A systematic review of patient-reported outcome measures.评估院外心脏骤停幸存者的健康相关生命质量(HRQoL):患者报告结局测量的系统评价。
Resuscitation. 2018 Feb;123:22-37. doi: 10.1016/j.resuscitation.2017.11.065. Epub 2017 Nov 27.
7
Patient-reported outcome measures in pediatric epilepsy: a content analysis using World Health Organization definitions.患者报告的儿科癫痫结局测量指标:使用世界卫生组织定义的内容分析。
Epilepsia. 2014 Sep;55(9):1431-7. doi: 10.1111/epi.12740. Epub 2014 Aug 15.
8
Assessment of content validity for patient-reported outcome measures used in patients with non-muscle invasive bladder cancer: a systematic review.非肌层浸润性膀胱癌患者使用的患者报告结局测量工具的内容效度评估:系统评价。
Support Care Cancer. 2018 Apr;26(4):1061-1076. doi: 10.1007/s00520-018-4058-8. Epub 2018 Feb 1.
9
The future of Cochrane Neonatal.考克兰新生儿协作网的未来。
Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12.
10
Patient-reported outcome measures for systemic lupus erythematosus clinical trials: a review of content validity, face validity and psychometric performance.系统性红斑狼疮临床试验的患者报告结局指标:内容效度、表面效度和心理测量性能综述
Health Qual Life Outcomes. 2014 Jul 22;12:116. doi: 10.1186/s12955-014-0116-1.

引用本文的文献

1
Biopsychosocial risk factors for pain in early phases of pediatric cancer treatment.儿童癌症治疗早期疼痛的生物心理社会风险因素。
Front Psychol. 2025 Apr 29;16:1507560. doi: 10.3389/fpsyg.2025.1507560. eCollection 2025.
2
Measuring Stigma in Pediatric Oncology: A Cross-Sectional Analysis of Three Global Sites.测量儿科肿瘤学中的耻辱感:对三个全球地点的横断面分析。
JCO Glob Oncol. 2025 Jan;11:e2400213. doi: 10.1200/GO.24.00213. Epub 2025 Jan 8.
3
Precision-guided treatment in high-risk pediatric cancers.精准制导治疗高危儿科癌症。

本文引用的文献

1
Barriers and Opportunities for Patient-Reported Outcome Implementation: A National Pediatrician Survey in the United States.患者报告结局实施的障碍与机遇:美国全国儿科医生调查
Children (Basel). 2022 Feb 2;9(2):185. doi: 10.3390/children9020185.
2
Inclusion of Patient-Reported Outcomes in Adolescent and Young Adult Phase III Therapeutic Trials: An Analysis of Cancer Clinical Trials Registered on ClinicalTrials.gov.将患者报告的结局纳入青少年和青年 III 期治疗试验:对 ClinicalTrials.gov 上注册的癌症临床试验的分析。
Value Health. 2021 Dec;24(12):1820-1827. doi: 10.1016/j.jval.2021.06.012. Epub 2021 Aug 8.
3
Nat Med. 2024 Jul;30(7):1913-1922. doi: 10.1038/s41591-024-03044-0. Epub 2024 Jun 6.
4
What are the anticipated benefits, risks, barriers and facilitators to implementing person-centred outcome measures into routine care for children and young people with life-limiting and life-threatening conditions? A qualitative interview study with key stakeholders.将以患者为中心的结局测量指标纳入到对患有危及生命疾病的儿童和青少年的常规护理中,预期会有哪些获益、风险、障碍和促进因素?一项针对主要利益相关者的定性访谈研究。
Palliat Med. 2024 Apr;38(4):471-484. doi: 10.1177/02692163241234797. Epub 2024 Mar 13.
5
Patient-reported outcome measures in children, adolescents, and young adults with palliative care needs-a scoping review.有姑息治疗需求的儿童、青少年和青年患者报告结局测量指标:范围综述。
BMC Palliat Care. 2023 Oct 6;22(1):148. doi: 10.1186/s12904-023-01271-9.
6
Patient-Reported Outcomes in Pediatric Patients With Cancer.患儿癌症患者的报告结果。
Am Soc Clin Oncol Educ Book. 2023 May;43:e390272. doi: 10.1200/EDBK_390272.
7
Outcome Measures and Patient-Reported Metrics in Cancer Rehabilitation.癌症康复中的结局指标与患者报告指标
Curr Oncol Rep. 2023 Aug;25(8):869-882. doi: 10.1007/s11912-023-01412-6. Epub 2023 May 6.
8
Ten Considerations for Integrating Patient-Reported Outcomes into Clinical Care for Childhood Cancer Survivors.将患者报告结局纳入儿童癌症幸存者临床护理的十点考量
Cancers (Basel). 2023 Feb 6;15(4):1024. doi: 10.3390/cancers15041024.
9
Patient Reported Outcomes and Measures in Children with Rhabdomyosarcoma.横纹肌肉瘤患儿的患者报告结局与测量指标
Cancers (Basel). 2023 Jan 9;15(2):420. doi: 10.3390/cancers15020420.
Health utilities in pediatric cancer patients and survivors: a systematic review and meta-analysis for clinical implementation.
儿童癌症患者和幸存者的健康效用:临床实施的系统评价和荟萃分析。
Qual Life Res. 2022 Feb;31(2):343-374. doi: 10.1007/s11136-021-02931-0. Epub 2021 Jul 5.
4
Identifying clinically meaningful severity categories for PROMIS pediatric measures of anxiety, mobility, fatigue, and depressive symptoms in juvenile idiopathic arthritis and childhood-onset systemic lupus erythematosus.确定青少年特发性关节炎和儿童发病的系统性红斑狼疮中 PROMIS 儿童焦虑、移动性、疲劳和抑郁症状测量的有临床意义的严重程度类别。
Qual Life Res. 2020 Sep;29(9):2573-2584. doi: 10.1007/s11136-020-02513-6. Epub 2020 May 14.
5
Thinking twice about sum scores.慎重考虑总和得分。
Behav Res Methods. 2020 Dec;52(6):2287-2305. doi: 10.3758/s13428-020-01398-0.
6
Using big data in pediatric oncology: Current applications and future directions.利用大数据进行儿科肿瘤学研究:当前的应用和未来的方向。
Semin Oncol. 2020 Feb;47(1):56-64. doi: 10.1053/j.seminoncol.2020.02.006. Epub 2020 Feb 29.
7
What are the attitudes of health professionals regarding patient reported outcome measures (PROMs) in oncology practice? A mixed-method synthesis of the qualitative evidence.卫生专业人员对肿瘤学实践中患者报告结局测量(PROMs)的态度是什么?定性证据的混合方法综合。
BMC Health Serv Res. 2020 Feb 10;20(1):102. doi: 10.1186/s12913-020-4939-7.
8
Refining scores based on patient reported outcomes - statistical and medical perspectives.基于患者报告结局的评分修正——统计和医学视角。
BMC Med Res Methodol. 2019 Jul 31;19(1):167. doi: 10.1186/s12874-019-0806-9.
9
State of the psychometric methods: patient-reported outcome measure development and refinement using item response theory.心理测量方法的现状:使用项目反应理论开发和完善患者报告结局测量指标
J Patient Rep Outcomes. 2019 Jul 30;3(1):50. doi: 10.1186/s41687-019-0130-5.
10
Symptom Biomarkers for Children Receiving Treatment for Cancer: State of the Science.接受癌症治疗儿童的症状生物标志物:科学现状
J Pediatr Oncol Nurs. 2019 Jul/Aug;36(4):280-286. doi: 10.1177/1043454219859233.